Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

In vivo SPECT/CT imaging of human ovarian carcinoma with monoclonal antibodies to EGFR and VEGFR-3 in mouse model

Tuulia Huhtala, Pirjo Laakkonen, Hanna Sallinen, Seppo Yla-Herttuala, Kari Alitalo and Ale Narvanen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1932;
Tuulia Huhtala
1University of Kuopio, AI Virtanen Institute, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pirjo Laakkonen
2University of Helsinki, Haartman Institute, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Sallinen
1University of Kuopio, AI Virtanen Institute, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seppo Yla-Herttuala
1University of Kuopio, AI Virtanen Institute, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari Alitalo
2University of Helsinki, Haartman Institute, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ale Narvanen
1University of Kuopio, AI Virtanen Institute, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 1932

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Tuulia Huhtala1,
  2. Pirjo Laakkonen2,
  3. Hanna Sallinen1,
  4. Seppo Yla-Herttuala1,
  5. Kari Alitalo2 and
  6. Ale Narvanen1
  1. 1University of Kuopio, AI Virtanen Institute, Kuopio, Finland
  2. 2University of Helsinki, Haartman Institute, Helsinki, Finland

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Apr 2015100
May 2015700
Jun 2015200
Sep 2015600
Nov 2015100
Mar 2016200
Apr 2016100
May 2016100
Jun 2016100
Jul 2016100
Aug 2016500
Nov 2016200
Dec 2016200
Jan 2017100
Mar 2017400
Apr 2017200
May 2017200
Jun 2017300
Jul 2017600
Aug 2017400
Oct 2017100
May 2018100
Jul 2018100
Sep 2018400
Nov 2018200
Feb 2019100
Apr 2019200
Nov 2019100
Dec 2019100
Feb 2020100
Mar 2020200
May 2020100
Jun 2020200
Aug 2020100
Dec 2020100
Jan 2021100
Feb 2021700
Mar 2021600
Apr 2021300
May 20211700
Jun 20211200
Jul 20215300
Aug 2021200
Sep 2021300
Oct 2021100
Nov 2021300
Dec 2021100
Jan 2022200
Feb 2022200
Mar 20221700
Apr 20222400
May 2022100
Jun 2022100
Jul 2022100
Aug 2022300
Sep 2022100
Oct 2022300
Mar 2023100
Apr 2023200
May 2023100
Jun 2023100
Jul 2023200
Aug 2023200
Sep 2023200
Oct 2023200
Nov 2023100
Dec 2023200
Jan 2024300
Feb 2024200
Mar 2024200
Apr 2024100
May 2024200
Jun 2024400
Jul 2024300
Aug 2024700
Sep 2024200
Nov 2024400
Dec 2024300
Mar 2025400
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In vivo SPECT/CT imaging of human ovarian carcinoma with monoclonal antibodies to EGFR and VEGFR-3 in mouse model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In vivo SPECT/CT imaging of human ovarian carcinoma with monoclonal antibodies to EGFR and VEGFR-3 in mouse model
Tuulia Huhtala, Pirjo Laakkonen, Hanna Sallinen, Seppo Yla-Herttuala, Kari Alitalo, Ale Narvanen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1932;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In vivo SPECT/CT imaging of human ovarian carcinoma with monoclonal antibodies to EGFR and VEGFR-3 in mouse model
Tuulia Huhtala, Pirjo Laakkonen, Hanna Sallinen, Seppo Yla-Herttuala, Kari Alitalo, Ale Narvanen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1932;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Analysis of tumor uptake of Iod-123-Methyltyrosine in fused PET-MRI in a mouse xenotransplantation model of pancreatic cancer
  • Evaluation of [64Cu]DOTA-annexin V radiotracer in the cycloheximide-induced liver apoptosis model
  • PET imaging of α-galactosidase A pharmacokinetics in rats and monkeys
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

New Radiopharmaceuticals-Oncology Posters

  • New Tc-carbonyl based octreotide derivatives
  • Estimation of radioiodinated PYK as an imaging agent for assessment of EGFR-TK activity
  • Synthesis of nitroimidazole derivatives for 68Ga labeling and test as a new ligand for imaging tumor hypoxia
Show more New Radiopharmaceuticals-Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire